This study tested a new drug called AB-2004 to see if it can safely reduce irritability in people with autism spectrum disorder. 156 participants took either the drug or a placebo for 8 weeks. The main goal was to measure changes in irritability using a standard behavior checklis…
Phase: PHASE2 • Sponsor: Vertero Therapeutics • Aim: Symptom relief
Last updated May 12, 2026 13:40 UTC